Oxford’s COVID-19 vaccine shows positive results

Oxford’s COVID-19 vaccine shows positive results

The world is still shaken by the coronavirus. Since its outbreak in Wuhan China at the end of last year, over 14,697,228 cases with 610,098 deaths have been reported worldwide, according to the Worldometer.

In the early stages of this current world pandemic, it was all about fear when images showing how people died in Wuhan City dominated the Internet. Although it wasn’t a death sentence later when some people started to recover naturally and change their perception of the virus earlier.

So far, over 8,775,137 have reported being recovered from this highly contagious virus after being infected. Nevertheless, the world has needed a possible, effective, and safest cure or vaccine to eradicate the fear associated with viruses.

The good news is that the COVID-19 vaccine developed by Oxford University shows some positive results, as it triggers an immune response in recipients and also appears to be safe. In the studies involved, 1,077 participants showed that they developed antibodies and T-cells that can fight COVID-19 after being injected the vaccine.

Although the finding is positive, it is still too early to conclude whether the developed antibodies and T cells are sufficient to trigger a permanent immune system. Regardless, the UK has already procured 100 million doses of the vaccine.

Oxford’s COVID-19 vaccine called ChAdOx1 nCoV-19 was developed at an unprecedented rate. It is based on a genetically modified virus that causes colds in chimpanzees.

Oxford University researchers then modified it to ensure that it wasn’t contagious to humans and to make it look exactly like Covid-19 in structure. Scientists achieved this by transferring the genetic content of the COVID-19 spike protein, which is a key ingredient in human cell invasion, to the vaccine they developed.

This implies that the resulting vaccine looked similar to COVID-19 and the human immune system can then learn to suppress it. While many other COVID-19 vaccines in development are primarily focused on antibodies, scientists have said that this is only part of our immune system.

The Oxford University vaccine also includes the use of T-cells, which are types of white blood cells that help coordinate our immune system and can recognize which of our body cells have been infected and destroy them.

Although the vaccine appears to be safe, it has some side effects. It is reported that around 70% of the those injected the vaccine developed some side effects such as headache and fever. However, the researchers say that this can be managed when administered in combination with paracetamol.

Prof. Sarah Gilbert of Oxford University said that much remains to be done before the vaccine can be confirmed effective against the COVID-19 pandemic, although the initial results are now promising.

While the study can’t show whether the vaccine can prevent people from getting sick or even relieving their COVID-19 symptoms, there are still steps that can go beyond this year.

The promising news, the vaccine is now some steps ahead and can be declared effective sooner what the world is waiting for.

Nelson Richards is a Seasoned Journalist with nearly 6 years of experience. While studying at Case Western Reserve University, Located at Cleveland. Nelson found a passion for finding and writing articles which are published in Well known Media Publications such as Tnt Publications and Ohio News Network. As a contributor to Chroniclex Nelson Covers National Topics.

Share this post